-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
(S)-Tenofovir
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/147127-19-3.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 147127-19-3 |
| Description | One isomer impurity of Tenofovir, which is an acyclic phosphonate nucleotide derivative, could be used in antiviral treatment as an everse transcriptase inhibitor. |
Product Information
| Synonyms | (S)-(((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic acid |
| IUPAC Name | [(2S)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid |
| Molecular Weight | 287.22 |
| Molecular Formula | C9H14N5O4P |
| Canonical SMILES | CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O |
| InChI | InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m0/s1 |
| InChIKey | SGOIRFVFHAKUTI-LURJTMIESA-N |
| Boiling Point | 616.1°C at 760mmHg |
| Melting Point | >260 °C |
| Flash Point | 326.4°C |
| Purity | > 95% |
| Density | 1.79g/cm3 |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | White to off-white crystalline powder or powder |
| Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
| Complexity | 354 |
| Exact Mass | 287.07834094 |
| Index Of Refraction | 1.739 |
| PSA | 146.19000 |
| Target | HIV; HBV |
| Vapor Pressure | 4.92E-16mmHg at 25°C |
| XLogP3-AA | -1.6 |
